Micro Crispr Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 16.01 Cr
as on 11-12-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 2521.88%
(FY 2023)
- Profit -3833.91%
(FY 2023)
- Ebitda -5065.58%
(FY 2023)
- Net Worth 1485.62%
(FY 2023)
- Total Assets 1592.15%
(FY 2023)
About Micro Crispr
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 16.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jacob Benjamin and Himmat Lodha serve as directors at the Company.
- CIN/LLPIN
U33309GJ2021PTC124575
- Company No.
124575
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2021
- Date of AGM
03 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Micro Crispr?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jacob Benjamin  | Director | 02-Aug-2021 | Current |
| Himmat Lodha | Director | 02-Aug-2021 | Current |
Financial Performance of Micro Crispr.
Micro Crispr Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2521.88% increase. The company also saw a substantial fall in profitability, with a 3833.91% decrease in profit. The company's net worth Soared by an impressive increase of 1485.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Micro Crispr?
In 2023, Micro Crispr had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Micro Synbio Private LimitedActive 2 years 3 monthsJacob Benjamin and Himmat Lodha are mutual person
- Micro Bio Immune Private LimitedActive 3 years 4 months
Jacob Benjamin and Himmat Lodha are mutual person
- Nuvo Health Ai Private LimitedActive 1 year 5 months
Jacob Benjamin and Himmat Lodha are mutual person
- Merai Accelerators Private LimitedInactive For E-Filing 8 months
Jacob Benjamin and Himmat Lodha are mutual person
- Micro Medicines Private LimitedActive 3 years 5 months
Jacob Benjamin and Himmat Lodha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Micro Crispr?
Micro Crispr has a workforce of 100 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Micro Crispr, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Micro Crispr's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
